Patients with early SLE had higher rates of unexplained fever than those with SLE-mimicking conditions.
Lupus nephritis in combination with impaired renal function is strongly associated with the presence of atherosclerosis in patients with systemic lupus erythematosus.
Researchers investigated the characteristics and outcomes of patients with systemic lupus erythematosus-associated thrombotic microangiopathy based on their ADAMTS13 inhibitor profiles.
The aPS/PT antibodies might represent markers of aPL-related pregnancy complications, such as intrauterine grown restriction and preeclampsia.
The incidence of zoster is high in systemic vasculitis and in patients with SLE exposed to intravenous cyclophosphamide.
Patients with SSc-SLE overlap syndrome were younger at diagnosis, had higher rates of pulmonary arterial hypertension, and less frequently had SSc cutaneous manifestations.
The risk for depression was increased significantly in patients with systemic lupus erythematosus and cutaneous lupus erythematosus.
Data indicate that drug-naive new onset systemic lupus erythematosus was likely to involve silent cardiac impairment.
Poor preconception cardiovascular health affects pregnancy outcomes in women with SLE.
The burden of entheseal sonographic changes was significantly higher in patients with SLE vs healthy participants, especially with respect to active inflammation.
Investigators sought to identify the risk factors for osteonecrosis and to identify the minimal investigations needed to monitor the risk for osteonecrosis in patients with systemic lupus erythematosus.
Researchers sought to assess the prevalence and characteristics of monophasic disease course in a defined cohort of patients with SLE.
Routinely available serologic markers have no correlation with tubulointerstitial damage in patients with lupus nephritis.
Erythrocyte-bound C4d may be useful in monitoring systemic lupus erythematosus.
Outcomes in systemic lupus erythematosus are largely influenced by level of poverty, type of neighborhood of residence, and chronic stress.
Investigators sought to evaluate changes in demographic, clinical, and histologic presentation in patients with lupus nephritis between 1970 and 2016.
Female patients with systemic lupus erythematosus who had musculoskeletal symptoms or positive antiphospholipid antibodies demonstrated higher titers of anti-double-stranded DNA antibodies.
Patients with systemic lupus erythematosus exhibit increased central arterial stiffness compared with a healthy control population.
The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.
Bisphosphonates and vitamin D may help prevent atherosclerosis in patients with systemic lupus erythematosus.
Rheumatology Advisor Articles
- Promising Antibody Markers Identified for aPL-Related Pregnancy Complications
- Comorbid Fibromyalgia Influences Disease Activity, Quality of Life in Axial Spondyloarthritis
- Efficacy of ABT-122 Maintained in Psoriatic Arthritis, Rheumatoid Arthritis at 36 Weeks
- Knee Load Associated With Increased Walking Pain in Osteoarthritis
- Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation
- Genetic Screening May Predict Osteoporosis, Fracture Risk
- Exploring the Clinical Implications of Cannabinoid Use in Rheumatoid Arthritis
- Diagnosing Lyme Disease in Children With Neuropsychiatric Illness
- Predicting Primary Nonresponse to Methotrexate in Rheumatoid Arthritis
- Prednisone, Prednisolone Does Not Adversely Affect Bone Mineral Density in RA
- Characteristics of Early-Onset SLE Distinguished From Mimicking Conditions
- Uric Acid Predicts AKI Risk After Cardiac Surgery
- Examining Gaps in Mental Health Care Among Youth With Juvenile Rheumatic Disease
- AMA Proposes Policy Opposing Medicaid 'Lockout' Provisions
- TNFi Not Linked to Increased Risk for Cancer Recurrence in Rheumatoid Arthritis